Tien-Li Lee

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Diego, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Nelson Sun, as Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Tien-Li Lee

Form 4 holding Director

Scilex Holding Co

Security class
Nonstatutory Stock Option (right to buy)
Shares / value
250,000
Estimated value
Report date
17 Jan 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director, 10%+ Owner

Aardvark Therapeutics, Inc.

Security class
Stock option (right to buy)
Shares / value
203,851
Estimated value
Report date
09 Feb 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director, 10%+ Owner

Aardvark Therapeutics, Inc.

Security class
Series A Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
14 Feb 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Tien-Li Lee

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .